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Background: Many studies have supported a number of associations between 
ABO blood type and certain diseases, including pancreatic cancer, venous 
thromboembolism, and myocardial infarction in the presence of coronary 
atherosclerosis, sexual maturity, breast cancer, cancer, infections, Diabetes 
mellitus, cardiovascular diseases ,hypertension, peptic ulcers, intelligence and 
socioeconomic class ,personality, suicide ,BMI and obesity . The ABO blood 
group is one such pivotal genetic determinant that can give valuable information 
for early detection of risk population. 
The present study aims to investigate and to reveal the relationship between ABO 
blood groups and body mass index (BMI) among Sudanese medical students 
Method: by using the cross –sectional study involve 105  medical students ,53 
male ,52 female ,in a group of age 16 and 32 International Africa University 
(IUA),faculty of medicine. Weight, height for BMI and blood groups were 
determined in order to find any association between ABO blood group and BMI.   
Result: Blood group O+ was most prevalent 28.6 % followed by A+ 25.7 %, B+ 
23.8 %, O- 8.6 %, AB+ 4.8, A- 4.8 %, B- 1.9 % and AB- 1. Obesity was 
insignificantly (p= 652) as in our study   we did not observe any significant 
difference regarding the ABO blood group in relation to  , BMI, and Rhesus blood 
group. The prevalence of overweight observed in this study is similar to that of a 
cross-sectional study conducted among sampled students in other studies. 
Conclusion: This study provides a ground for future research to confirm or refute 





 بما ، األمراض وبعض ABO الدم فصيلة بين االرتباطات من عددًا الدراسات من العديد دعمت :لخلفيةا
 الشرايين تصلب وجود في القلب عضلة واحتشاء ، الوريدية الدموية الجلطات ، لبنكرياس فيذلكسرطانا
 وأمراض ، السكري ومرض ، والتهابات ، والسرطان ، الثدي وسرطان ، الجنسي والنضج ، التاجية
 ، واالقتصادية االجتماعية الطبقة ، الهضمية القرحة ، الدم ضغط ارتفاع ، واألوعيةالدموية القلب
 الوراثية ات المحدد أحد ABO فصيلةالدم تعد .والسمنة الجسم كتلة مؤشر ، االنتحار ، الشخصية
 .للخطر المعرضين السكان عن لمبكر للكشفا قيمة معلومات تعطي أن يمكن التي المحورية
 كتلةالجسم  ومؤشر ABO فصائاللدم بين العالقة عن والكشف التحقيق إلى الدراسة هذه تهدف :الطريقة
(BMI) الذكور من 53 ، الطب طالب 105 تشمل مقطعية دراسة باستخدام السودانيين الطب طالب بين ، 
 الوزن تحديد تم .الطب كلية ، (IUA) عالميةال إفريقيا جامعة 32 و 16 سن من مجموعة في ، أنثى 52
 كتلة ومؤشر ABO فصيلةالدم بين أيارتباط إيجاد أجل من الدم وفصائل الجسم كتلة لمؤشر والطول
 .الجسم
 ، A + 25.7٪ ، B + 23.8٪ تليها ، ٪28.6 بنسبة انتشاًرا أكثر + O الدم مجموعة كانت :النتيجة
O- 8.6٪ ، AB + 4.8 ، A- 4.8٪ ، B- 1.9٪ و AB- 1. 652 = ع) غيرملحوظة السمنة كانت) 
 الدم بفصيلة يتعلق فيما ABO لدما  بفصيلة يتعلق فيما مهم يفرق لمنالحظأ ، دراستنا في الحال كماهو
BMI و Rhesus. مقطعية دراسة انتشار الدراسة هذه في لوحظت التي الوزن زيادة تشار يشبهان 
 .أخرى دراسات في العينة طالب بين أجريت
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 1.1   Background: 
The distribution pattern of the ABO blood antigen varies by the prevalence type 
among different populations in the world. The association between ABO blood 
group and several elements of the human population such as intelligence (1), 
socioeconomic status (2), diet (3), diseases (4), and others has long been suggested. 
Some of these reports such as from Gibson et al. (1) and Beardmore and Karimi 
Booshehri (2) linking ABO blood  type to intelligence and socioeconomic class, 
respectively, have been decades old, and the potential mechanism by which ABO 
antigens determine these consequences was not underscored. Furthermore, 
D’Amato’s (3) popular blood type diet, without proven scientific evidence, was 
theoretically based on the belief that each ABO blood group carries the genetic. 
According to World health organization, body mass index (BMI) is defined as a 
simple index of weight-for-height that is commonly used to classify underweight, 
overweight and obesity in adults. It provides a measure to determine the 
distribution of fat in children and adults. The precision of measurements of height 
and weight suggests that a variant for height for weight provides a more reliable 
measure of adiposity within populations (5, 6). Obesity and overweight both are 
harmful for health (7). Obesity that is defined by World Health Organization 
(WHO) as abnormal and excessive fat accumulation (8) has become an epidemic 
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due to changing eating habits and inactive life style (9). According to WHO Fact 
Sheet, there were more than 1.9 billion adults (18 years and older) and 41 million 
children (5 years and younger) who were overweight in 2014 (3). This shows that 
obesity and overweight has become a serious problem in the world. 
ABO blood group and BMI have individually been appraised as risk factors for 
certain illnesses, few studies (11 – 13) have been conducted to examine whether 
carrying a particular ABO blood antigen potentially predisposes one to higher body 
mass index. These studies, have arrived at different conclusions on whether ABO 
status associates or does not associate with BMI .Due to the racial and ethnic 
disparities existing among different people globally, population-based studies are 
relevant. To our knowledge, no study has been done to test the association of BMI 
and ABO blood group in a Sudanese people. 








1.2 Justification:  
This study was undertaken to investigate the distribution and association of ABO 
















 1.3 Objectives: 
 1.3.1 General objective: 
To investigate the distribution and association of ABO blood group and BMI 
categories in a Sudanese population. 
1.3.2 Specific objectives: 
To measure the ABO antigens among study groups 
To measure rhesus antigen among study groups  











 2. Literature Review 
2.1 History of blood antigen:  
An ancient ABO-like gene is believed to have existed as early as 40 million years 
ago with the evolution of the ABO gene starting at least 13 million years ago (14). 
Several phylogenic studies suggest that A, B and O lineages developed between 1 
to 4 million years ago (15). In 1901 Karl Landsteiner reported testing red blood 
cells and sera from six healthy men and discovery of the ABO blood group system, 
for which he earned the Nobel Prize in 1930. In 1911 von Dungern and Hirschfeld 
reported the distribution of blood group A (47 %), B (11%), AB (6%) and O (36%) 
in Europeans, and separation of blood group A into A1 and A2. In 1926 and 1930 
Yamakai, Lehres and Putkonen found soluble ABO blood group substances in 
secretions and could divide them into two groups, secretor and non-secretor (16). 
In 1924 Bernstein proposed the theory of inheritance (17) that still holds true 
today. Several researchers isolated ABO blood group determinants from 
glycoproteins (reviewed by Morgan & Watkins 2000)(16) and the study of ABO 
glycolipids became popular, with most of the basic ABO structures being resolved 
during this period (18, 19). On  the back of the new genetics revolution Yamamoto 
identified cDNA of the α1→3N-acetylgalactosaminyl transferase (A-transferase) 
(20) in 1990, and by doing so opened the door for genomic studies of ABO blood 
group system. For the next 20 years a wave of ABO gene discovery continued and 
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by 2009 a total of 215 ABO alleles had been reported (21), and new alleles still 
continue to be identified and reported (22).  
2.2  The ABO System: 
The ABO blood group system is defined by the presence or absence of two 
antigens (A and B) and is recognized as four major blood group phenotypes A, B, 
AB and O. The antigens are inherited according to Mendel’s law, where one 
haplotype from each parent is inherited. The frequency in the European population 
is reported as blood group A 41.7%, B 8.5%, AB 3.0% and O 46.7% (23), but the 
frequency varies significantly in different ethnic groups.   
ABO antigens exist on glycoproteins and glycolipids in red cell membranes and 
also on most cells and tissues in humans, and in animal tissues. The antigens are 
also present in the secretory fluids in the majority of humans. Thus the term 
“histoblood group system” is a more accurate description than “blood group 
system”. The antigens are unequally expressed among and within the different 
cells and tissues and in different species (24, 25). Except for humans, only 
anthropoid apes, the orangutan and the gorilla have ABO antigens on their red 
cells, which suggest that the red cells are the last cells during evolution to obtain 
the ABO antigens (23).  A, B and H antigens are carbohydrate molecules built 
stepwise from saccharides such as galactosamine (GalNAc), glucosamine 
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(GlcNAc), fucose (Fuc), galactose (Gal), and glucose (Glc). The synthesis is 
catalyzed by glycosyltransferases encoded by the ABO genes, and thus A and B 
antigens are secondary gene products. The major alleles at the ABO locus are A, B 
and O and to-date a number of ABO blood groups variants have been reported, 
with approximately 250 different alleles registered in the Blood Group antigen 
gene Mutation database (BGMUT) (26).   
 2.2.1 ABO Genetics:   
The ABO gene is located at the long arm of chromosome 9q34 [27] and consists of 
seven exons and introns, covering approximately 20 kilo base pairs from the 
initiation to the stop codons. The nucleotide sequence of the A allele cDNA 
consists of 1062 base pairs, and encodes the enzyme protein (28). The cDNA (the 
A1 allele, [A101]) encoding the N-acetylgalactosamine transferase was cloned and 
sequenced by Yamamoto et al (20) and is considered as the consensus (index) gene 
against which all other variant of ABO genes are compared.  The ABO genes are 
very polymorphic both between and within the blood groups; however several 
main mutations in the genes are characteristic for some ABO blood groups. The 
A2 allele [A201] has a substitution at nucleotide 467 (C>T) and a deletion (C) 
involving nucleotides 1059 to 1061, which extend the transferase with 21 amino 
acids, causing a less effective enzyme (29).   
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 2.2.2 ABO glycosyltransferases:  
ABO antigens are secondary products of ABO gene defined specific enzymes, so 
called glycosyltransferases. N-acetylgalatosaminyltransferase (GTA) and 
galactosyltransferase (GTB) are the enzymes encoded by the ABO genes. GTA 
and GTB catalyze the transfer of GalNAc (using UDP-GalNAc) or Gal (using 
UDPGal) to the OH-3 position of the terminal Gal of the H structure (Fucα2Gal) to 
create A and B antigens, respectively (33). Manganese ions (Mn2+) are required as 
a co-factors and the disaccharide Fucα1-2Gal residue is the minimal required 
acceptor. These glycosyltransferases, and others that construct the requisite 
precursors, reside mostly in the endoplasmatic reticulum (RE) and Golgi apparatus. 
The glycosyltransferases are type II transmembrane proteins, and exist both 
membrane-bound and as soluble proteins in plasma and other body fluids. The 
membrane-bound enzyme has a short cytoplasmic N-terminal tail, a hydrophobic 
transmembrane domain, a stem region, plus a large C-terminal which constitutes 
the catalytic domain. The soluble transferases lack the N-terminal and the 
hydrophobic transmembrane domain (33). 
2.2.3 ABO biochemistry:  
The majority of ABO antigens on red cells are linked to glycoproteins 
(approximately 70%), thus they very much influence the blood group activity on 
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the red cells. However this thesis only describes glycolipids and very little will be 
mentioned about the unknown contribution of glycoproteins to the phenotype. 
Glycolipids are chosen because they are relatively structurally less complex than 
glycoproteins, easier to isolate to homogeneity, are usually representative of a 
single biosynthetic process, and can be relatively easily structurally resolved.  The 
ceramide part in the glycolipid is formed by a fatty acid in amide linkage to a 
sphingosine, which is anchored in the cell membrane (36). The configuration of the 
carbohydrate chain of the four core structures (table 1) differs and can cause the 
ABO glycotopes to be presented differently on the surface membrane. Type 1 is 
nearly vertical to the cell membrane while type 2, 3 and 4 are bent more or less 
parallel in their minimum energizing state. Furthermore, rotations of the 
carbohydrate chains may cause the A determinant to point in different directions. 
This presentation of the antigen on the cell surface may affect the susceptibility for 
antibody and microbial binding (37).  
Other than the A1 and A2 phenotypes the contribution of the various ABO antigen 
bearing structures to the serological phenotypes observed is largely unknown.  
2.2.4 Relation of ABO system with other Groups 
The ABO Blood group system is discovered by the Austrian scientist Karl 
Landsteiner, who found three different blood types in 1900. He was awarded 
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Nobel Prize in 1930.  Alfred Von Decastello and Adriano Sturli discovered the 
fourth type 'AB' in 1902 (38).  
The epitopes of ABO antigens are determined by carbohydrates (sugars), which are 
linked either to polypeptides (forming glycoproteins) or to lipids (glycolipids). 
Antigenic differences between different species were recognized before differences 
within a species. Landois discovered that when the red blood cells of an animal, 
e.g. a lamb, when mixed with the serum of another animal (a dog) and incubated at 
370C they will be lysed within 2 min (39).Landsteiner was prompted by the work 
of Landois to see whether it was possible to demonstrate differences, although 
presumably slighter ones, between individuals of the same species.  As he later 
explained, he chose the simplest plan of investigation and simply allowed serum 
and red cells from different human individuals to interact (40). He discovered that 
the red cells agglutinate if blood is incompatible and lead to discovery of ABO 
blood group system. 
2.2.5 MNS systems: 
After the discovery of the ABO Blood group system no new blood group systems 
were found for 25 years. Landsteiner and Witt examined human sera for antibodies 
other than anti-A and anti-B but could find only weak agglutinins active at low 
temperatures (41). It occurred to Landsteiner and Levine that they might be able to 
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reveal other antigens by injecting different samples of human red cells into rabbits. 
Antibodies identifying three new human antigens were obtained (42); to the first of 
these the letter M was given to indicate that the antigen had been identified with 
immune serum ('I' was avoided because of confusion with the numeral (43). 
 2.2.6 The Rhesus System: 
Antibodies demonstrating Rh polymorphism in humans were found in two 
different ways. Landsteiner and Wiener injected the red cells of rhesus monkeys 
into rabbits and guinea pigs and tested the resulting serum against human red cells 
(44). Meanwhile, Levine and Stetson in 1939 found an antibody (which 
subsequently proved to be anti-Rh) in the serum of a recently delivered woman 
whose fetus had died in utero (45). 
2.2.7 Bombay Blood Group H-antigen: 
H-antigen is the precursor to the ABO blood group antigens. It is present in all 
RBCs irrespective of the ABO system. Persons with the rare Bombay phenotype 
are homozygous for the H gene (HH), do not express H-antigen on their RBCs. As 
H-antigen acts as precursor, its absence means the absence of antigen A and B. 
However, the individuals produce iso-antibodies to H-antigen as well as to 
antigens A and B (46). 
12 
 
Individuals belonging to Bombay blood group (oh) (46) are homozygous for the 
absence of H gene i.e., they are of the genotype 'hh', so that they are unable to 
bring about the initial part of conversion of the precursor blood group substance 
(47). This means that even if 'A' and 'B' genes are present, they have no substrate 
for their normal function of producing 'A' and 'B' blood group substances (48). The 
ABO genes cannot therefore be expressed and such individuals appear to belong to 
'O' but their true state can be detected because of the presence in their serum of 
anti-H .Thus the 'Bombay phenotype' , lack 'A', 'B' and 'H' antigens on their 
erythrocytes  and in secretions. Nevertheless they appear to have normal 'A' and 'B' 
genes that can be expressed in the next generation if their children acquire an 'H' 
gene from the other parent (49). It follows that there is no 'O' antigen; group 'O' 
erythrocytes and the saliva of group 'O' secretors contain 'H' antigen, but the 
designation group 'O' erythrocytes has been retained for historical reasons (50). 
2.2.8 Lewis Blood Group System: 
The Work of Mourant (1946) and subsequent work of Grubb (1951) and Ceppellini 
(1955)( 51) showed that Lewis antigen is also found on red blood cells and is 
related to ABO system and secretion of ABH antigens. There are two types of 
Lewis antigen and designated as Lea  and Leb   respectively, and give rise to three 
red blood cell phenotypes which are designated as Le( a - b+ ), Le( a + b - ), Le(a - 
b - ). The synthesis of Le antigen is regulated by the independent gene Le. The 
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Lewis antigen appears on the same glycoproteins as the ABH determinants (51). 
These antigens are synthesized from the same precursor substance as ABH antigen 
(52). 
2.2.9 Other blood group systems: 
The structure and functions of the membrane proteins and glycoprotein carrying 
blood group antigens have been reviewed by carton (53)and Daniels(54) .The H 
antigen content of red cells depends on the ABO group and when assessed by 
agglutination reactions with anti-H, the strength of reaction tends to be graded O> 
A2 > A2B > B > A1 > A1B. Other subgroups are occasionally found. The A, B, 
and H antigens are detectable early in fetal life but are not fully developed on the 
red cells at birth.  The number of antigen sites reaches adult level at around 1 year 
of age and remains constant until old age, when a slight reduction may occur. The 
ability to secrete A, B and H substances in water soluble form is controlled by 
FUT2 (dominant allele Se).  
Between 1946 and 1971 the Kell (K), Duffy (Fy), Kidd (Jk), Diego (Di), 
Cartwright (Yt), Xg, Sc, Dombrock (Do) and Colton (Co), Lewis and Lutheran 
blood group systems were discovered.  As shown in table 1.0, twenty-five blood 
group systems have been given numbers so far (41).  In numerical order, systems 
14 
 
001-025 are: ABO, MNSs, P1, Rh, Lu, Kell, Lewis, Fy, Jk, Di, Yt, Xg, Sc, Do, Co, 
LW, Chido/Rodgers, Hh, Kx, Ge (Gerbich),  Cromer, knops, Indian, Ok.MER2  
2.3 Important of ABO system: 
Epstein and Ottenberg in 1908 suggested that ABO blood groups were inherited, 
and this was confirmed by Von Dungern and Hirsfeld in 1910.  The exact manner 
was published by Bernstein in 1924(55). Attempts were made earlier to 1900, to 
replace blood, for example, in cases of hemorrhage, by transfusion of a donor's 
blood. In some instances, the therapy met with success and in some severe as well 
as fatal hemolytic reaction occurred. In other words, blood of some people was 
compatible and that of others incompatible. One could not understand the cause of 
this phenomenon at that time and they attributed it to some unknown 









Table 1. Blood group systems recognized by the ISBT working party 
System  
number 
System name  
conventional 





1 ABO ABO 9q34.1-q34.2 ABO 
2 MNS MNS 4q28-q31 GYPA,  
GYPB 
3  P PI 22q11.2-qter P 
4 Rh RH 1p36.2-p34 RHD, RHCE 
5 Lutheran LU 19q12-q13 LU 
6 Kell KEL 7q33 KEL 
7 Lewis LE 19p13.3 FUT3 
8 Duffy FY 1q22-q23 FY 
9 Kidd JK 18q11-q12 HUT11 
10 Diego DI 17q12-q21 SLC4A1 
11 Yt YT 7q22 ACHE 
12 Xg XG Xp22.32 XG 
13 Scianna SC 1p36.2-p22.1 SC 
14 Dombrock DO 12p13.2-p12.1 DO 
15 Colton CO 7p14 AQP1 
16 LW LW 19p13.2-cen LW 
17 chido/Rogers CH/RG 6p21.3 C4A,C4B 
18 H H 19q13 FUT1 
19 Kx XK Xp21.1 XK 
20 Gerbich GE 2q14-q21 GYPC 
21 Cromer CROM 1q32 DAF 
22 Knops KN 1q32 CR1 
23 Indian IN 11p13 CD44 
24 Ok OK 19pter-p13.2 OK 
25 MER2 RAPH 11p15 MER2 
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In 1875, Landois noticed that if red blood cells of an animal of one species were 
mixed with serum from an animal of another species, clumping or agglutination of 
red blood cells usually occurred (55).The phenomenon was recognized as being 
similar to that which followed the mixing of bacteria with appropriate immune 
sera. 
Landsteiner from his observations stated “if an agglutinogen is present on the red 
blood cells of a blood, the corresponding agglutinin is absent from the plasma; if 
the agglutinogen is absent the corresponding agglutinin must be present (56). This 
statement is popularly known as Land Steiner's law. The Landsteiner law, 
however, is not always true, for example, 'Rh' negative persons need not and 
normally do not contain anti-Rh agglutinin but may develop the agglutinin as a 
result of immunological response (Sensitization). When 'Rh' positive red blood 
cells enter the subject's circulation during blood transfusion or maternal circulation 
from the 'Rh' positive foetus. 
Landsteiner (1901) and later workers, namely, Jansky (1907) and moss (1907) 
showed that the red blood cells of all the individuals can be grouped according to 
the presence of two blood group substances or agglutinogens called 'A' and 'B', into 
four main blood groups 'A', 'B', 'AB'  and 'O' (57). Table 2.0 shows blood group 




Group 'A' is further subdivided into 'A1' and 'A2'. Anti-A serum contains two 
antibodies anti-A and anti-A1; it is generally believed that 'A1' has two antigens, 
'A' and 'A1', while 'A2' has only one 'A'. 'A2' cells react weakly with anti-A serum; 
hence a high titre serum is necessary while grouping; 'A2B' cell react even less 
readily with anti-A serum.  The subgroups of An increase the number of groups 
from four to six; 'A1' ,'A2' ,'B',  'A1B' , 'A2B' and  'O.'  
The main four groups of ABO system are inherited as Mendelian characters by 
three allelic genes, A, B, and O 
(Thompson, R.B. et al.,). The dominant 'A' and 'B' determine the presence or 
absence of the corresponding blood group substance so that an individual who 
inherits an A gene from each parent will be of genotype 'AA', and similarly with 
'B'. The inheritance of 'A' from one parent and 'B' from the other will result in the 
genotype 'AB'. The 'O' gene may be paired with either 'A' or 'B' but has no 
suppressive effect so that an individual of genotype 'AO' or 'BO' reacts as group 'A' 
or 'B' respectively. When 'O' gene inherited from each parent the genotype is 'OO' 






          Table 2. Genotyping of ABO system                          
Genotype     Group 
AB                                                                   AB 
AA or AO                                                          A 
BB or BO                                                          B 
OO O 
                                                    
 2.4 Rhesus group: 
The Rh blood group system was first described 60 years ago. A woman had a 
severe transfusion reaction when she was transfused with blood from her husband 
following delivery of a stillborn child with erythroblastosis fetalis. Her serum 
agglutinated red blood cells (RBCs) from her husband and from 80% of Caucasian 
ABO compatible donors (58). 
The following year, Landsteiner and Wienr (59) found that sera from rabbits (and 
later guinea pigs) immunized with RBCs from Macaca mulatta (Macacus rhesus in 
the original paper) agglutinated 85% of human RBC samples. Initially, it was 
thought that the animal and human antibodies identified a common factor, Rh, on 
the surface of rhesus and human RBCs. It was soon realized that this was not the 
case (60). Therefore, the original terms (Rh factor and anti-Rh) coined by 
Landsteiner and Wiener, although being misnomers, have continued in common 
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usage. The heteroantibody was renamed anti-LW (after Landsteiner and Wiener), 
and the human alloantibody was renamed anti-D (61). 
Even after Karl Landsteiner’s discovery in 1900, transfusion reactions were still 
prevalent (62). It was not until 1940 when Landsteiner and Weiner discovered the 
Rh factor that transfusion medicine involved less risk. Immunogenicity of the Rh 
factor along with A, B antigens made it mandatory for pre-transfusion testing (63). 
Currently there are more than 50 antigens in the Rh blood group system but the 
principal Rh antigens of medical interest are D, C, E, c and e (16). A person with 
Rhesus antigen is referred to as Rhesus positive while individuals lacking the 
antigen are Rhesus negative. When a Rhesus negative person is exposed to Rhesus 
positive blood, antibodies will be produced, which cause potentially fatal 
haemolytic reactions 
2.5 Body Mass Index (BMI): 
Body mass index (BMI) is a mathematical calculation that estimates a person’s 
health status based on his height and weight (65). BMI is used generally to assess a 
person’s risk for various chronic diseases such as diabetes, cardiovascular disease, 
stroke, cancer and numerous more (65). BMI functions by categorizing people into 
four different weight categories that are used to classify a person’s health and 
allows physicians and researchers to easily communicate with the public about 
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potential health issues encountered in that category (66). Much of the initial 
research was performed over a decade ago; however, there is some still being 
performed today. Researchers have and continue to look at the link between BMI 
and chronic diseases such as diabetes, hypercholesteremia, and hypertension, as 
well as its association with waist circumference. Along with this, researchers have 
expanded their research to new areas involving BMI like looking at childhood BMI 
as a potential predictor of health later in life.   
BMI and waist circumference Body mass index and waist circumference are two 
measurement tools commonly used to evaluate obesity. Chinedu et al. (67) 
examined the two tools to see if there was a correlation between them. They 
examined 489 Nigerian participants aged 18-75 years for waist circumference, 
height, and weight. The results showed a significant, positive relationship between 
BMI and waist circumference (r=0.75) indicating that as BMI increased so did 
waist circumference. Additionally, Gierach et al. (68) found similar results in a 
study of 839 participants aged 32-80 years diagnosed with metabolic syndrome. 
Researchers found that waist circumference was significantly associated with BMI 
(r=0.78) again indicating that with a higher BMI, participants tended to have a 
larger waist circumference. This correlation was stronger in women compared to 
men. However, no potential explanation was given for this. Abdominal obesity has 
frequently been studied and is determined to be a major factor in metabolic 
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syndrome. Nahuelcuera and Barria also found these results in a group of 188 
Chilean adolescents and young adults aged 3-25 years (69) which suggests that this 
relationship may be present throughout the lifespan. Romero-Corral et al. (70) 
examined body mass index compared to bioelectric impedance analysis to 
determine body fat percentage. The cross-sectional study included 13,601 U.S. 
citizens excluding individuals that were unable to receive bioelectric impedance.  . 
They found that BMI has a high specificity for detecting obesity but has a poor 
sensitivity meaning it often misses 
 2.5.1 Obesity: 
Obesity that is defined by World Health Organization (WHO) as abnormal and 
excessive fat accumulation (82) has become an epidemic due to changing eating 
habits and inactive life style (83). According to WHO Fact Sheet, there were more 
than 1.9 billion adults (18 years and older) and 41 million children (5 years and 
younger) who were overweight in 2014 (84). This shows that obesity and 
overweight has become a serious problem in the world. It has been reported that 
obesity is an important risk factor for some types of diseases, such as metabolic 
syndrome, type 2 diabetes, cardiovascular diseases and cancer (85). Especially, 




 2.5.2 Body mass index and ABO System: 
There were attempts to disclose a possible relationship between ABO blood groups 
and various diseases in related literature. The potential relationship between ABO 
blood groups and various diseases, such as ischemic heart disease, coronary artery 
disease (87, 88), cancer (89), cardiovascular diseases (90), etc., have been 
investigated by many researchers for a last two decades. These studies have shown 
the strong relationship between blood groups and such diseases. This relationship 
contributes to diagnosis of the disease and supports the possible preventive 
measures to decrease the incidence (91).  Additionally, several studies on 
relationship between ABO blood group and obesity has been also performed on 
different communities and subjects. Behera et al. (83) found that the blood group 
aB and rh (–) was associated with the highest number of obese subjects. 
Sukalingam and ganesan (92) and Qunq and abdel Hamid (93) revealed that the 
patients with blood group B were more susceptible to be obese compared to those 
with the other blood groups. Ainee et al. (94) and Krishnakanth et al. (95) found 
higher incidence of obesity among the children with blood group O as compared to 
children with the other blood groups. On the other hand, Jafari et al. (96) and 
Mascie-Taylor and lasker (97) revealed that there was no relationship between 
blood groups and BMI. Although ABO blood group and BMI have individually 
been appraised as risk factors for certain illnesses, few studies (98) have been 
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conducted to examine whether carrying a particular ABO blood antigen potentially 
predisposes one to higher body mass index. There are studies claiming relation of 
ABO blood groups to overweight and obesity (99). Some studies concluded that 
there was no association between development of obesity and a particular blood 
group. (100). Even though the blood group is a non-modifiable risk, having 
knowledge of association between obesity and blood group can help to make 
healthy life styles. These healthy life styles can be implemented in early life of at 












 3. Methodology 
  3.1 Study design: 
Cross-sectional descriptive study.   
3.2 Study area: 
This study was conducted in Faculty of Medicine, Africa International University. 
 3.3 Study population: 
Study population was included all Sudanese student in the Faculty of Medicine, 
Africa International University. 
 3.4 Sample size: 
This is convenience study; sample size will be included one hundred thirty 
participants. 
 3.5 Data collection: 
ABO and Rhesus antigens measurement: 
All the blood samples were collected between 8am and 12 noon’s each day. Blood 
samples (5mls) were obtained from each subject by veno-puncture into EDTA 
(ethylenediaminetetacetic salt) bottle and used for determination of blood groups 
and Rhesus factors. For ABO blood grouping, a drop of antiserum A, antiserum B 
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and anti AB was placed in clean tile and labelled 1, 2, and 3.  To each anti sera was 
added a drop of 5% red blood cells, mixed thoroughly and observed for 
agglutination.   
Similarly, for Rhesus D typing a drop of anti D serum was placed in   a clean 
labelled tile, mixed with a drop of blood and watch for agglutination. 
 3.6 Anthropometric measurements: 
 Weight and height: 
Calibrated weight measure scale was used weight measurement. Firstly, the person 
was asked to remove any heavy clothes or items; then person’s feet were set onto 
the centre of the scale platform with feet slightly a part for better balance, and ask 
person to look straight and then record the weight.  
For height measurement; the person was asked to remove his/her shoes prior to 
taking measurement; person was stand with his/her feet slightly a part and back as 
straight as possible with the heels, shoulder touch the surface of height board. 
Person will be asked to look straight ahead with head erect, the headpiece was 
placed flat against the wall at a right angle to the head, the headpiece was lowered 





 3.7Anthropometric measurements of Body mass index (BMI): 
BMI was calculated as weight kg/height squared (kg/m
2
) and subjects were 
considered as underweight if their BMI were less than 18, normal weight if their 
BMI between 18 and 25, overweight if their BMI between 26 and 30 and obese if 
their BMI more than 30. 
 3.8 Statistical analysis: 
Statistical Package for Social Science was used to analysis data. Data were 
presented as mean ± Std.  Descriptive statistics of the mean standard deviation and 
standard error was used to examine the data. Student’s t test for nonparametric data 
was used to compare the difference between the means of the two investigated 
parameters. The Pearson chi-square correlation analysis was used to determine the 
association between BMI and ABO blood group. Percentages for independent 
variables were calculated, and p<0.05 will be considered statistically significant. 
Ethical consideration: 
Ethical approval was obtained from Faculty of Medicine, Africa International 
University committee. Written informal consent was obtained from each 
participant in this study. 
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 4. Results: 
Descriptive statistics of study group: 
As shown in table (3) the mean age of study participants was 19.89 ± 3.99 year and 
mean of height and weight were 168.97 ± 8.44 cm and 64.68 ± 15.14 kg 
respectively. The mean of systolic blood pressure of study participants were 118.79 
± 16.37 mmgH and the mean of diastolic blood pressure of study participants were 
74,93 ± 8.02. 
Table (3) Descriptive statistics of study participants 
 
Descriptive Statistics 
 N Minimum Maximum Mean Std. Deviation 
Age 102 16 36 19.89 3.992 
      
Height 104 153 197 168.97 8.447 
Weight 105 35 112 64.68 15.146 
Systolic 57 80 177 118.79 16.378 
Diastolic 57 60 90 74.93 8.022 
Valid N (listwise) 55     
 
Gender distribution of study participants: 
In our study 50.5 % of study participants were male and 49.5 % of the study 





Table (4) Gender distribution of study participants  
Sex 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid Male 53 50.5 50.5 50.5 
Female 52 49.5 49.5 100.0 
Total 105 100.0 100.0  
 
 
Blood group of participant’s distribution: 
Blood group O+ was most prevalent 28.6 % followed by A+ 25.7 %, B+ 23.8 %, 
O- 8.6 %, AB+ 4.8, A- 4.8 %, B- 1.9 % and AB- 1 %. Table (5).  
Table (5) blood group of participant’s distribution  
Blood Group 




Valid A+ 27 25.7 26.0 26.0 
B+ 25 23.8 24.0 50.0 
O+ 30 28.6 28.8 78.8 
A- 5 4.8 4.8 83.7 
B- 2 1.9 1.9 85.6 
O- 9 8.6 8.7 94.2 
AB+ 5 4.8 4.8 99.0 
AB- 1 1.0 1.0 100.0 
Total 104 99.0 100.0  
Missing Syste
m 
1 1.0   







Table (6) association of ABO blood group and BMI 
Blood Group * BMI  























A+ Count 24 2 0 1 27 
% within 
Blood_Group 
88.9% 7.4% 0.0% 3.7% 100.0% 
B+ Count 20 3 1 0 24 
% within 
Blood_Group 
83.3% 12.5% 4.2% 0.0% 100.0% 
O+ Count 23 1 4 2 30 
% within 
Blood_Group 
76.7% 3.3% 13.3% 6.7% 100.0% 
A- Count 4 0 1 0 5 
% within 
Blood_Group 
80.0% 0.0% 20.0% 0.0% 100.0% 
B- Count 1 1 0 0 2 
% within 
Blood_Group 
50.0% 50.0% 0.0% 0.0% 100.0% 
O- Count 8 1 0 0 9 
% within 
Blood_Group 
88.9% 11.1% 0.0% 0.0% 100.0% 
AB+ Count 5 0 0 0 5 
% within 
Blood_Group 
100.0% 0.0% 0.0% 0.0% 100.0% 
AB- Count 1 0 0 0 1 
% within 
Blood_Group 
100.0% 0.0% 0.0% 0.0% 100.0% 
Total Count 86 8 6 3 103 
% within 
Blood_Group 




Table (7) Chi-Square Tests degrees 
 
Chi-Square Tests 






Likelihood Ratio 18.429 21 .622 
Linear-by-Linear 
Association 
.063 1 .802 
N of Valid Cases 103   
 
P value = .652   is more  than 0.05 so it’s considered insignificant  
 
To investigate the distribution and association of ABO blood group and BMI 











 5.1 Discussion: 
The aim of our present study is investigated the distribution and association 
between blood group antigens, BMI categories and blood pressure. Our results 
demonstrated that Blood group O+ was most prevalent 28.6 % followed by A+ 
25.7 %, B+ 23.8 %, O- 8.6 %, AB+ 4.8, A- 4.8 %, B- 1.9 % and AB- 1 %. In 
addition, our study did not observe any significant difference regarding the 
association between blood group antigens (ABO and Rhesus factor), BMI and 
blood pressure. 
Previous study had reported the great importance of ABO blood group system in 
determining disease and health states. Not only ABO blood group system is 
important for determining hypertension, erythroblastosis fetalis, and blood 
transfusion and exchange reactions (101) but has also been shown to be relevant to 
conditions such as osteodysplasia and as genetic marker of obesity (101). More 
recent developments are exploring the relationship between ABO blood grouping 
and obesity (102), which was also one of the main objectives of current study. 
Relationship between Lewis blood grouping and obesity was extensively studied 
by Hein HO and his colleagues (102) and many other researchers; however the 
association between ABO blood group system and obesity is still to be 
hypothesized due to conflicting results documented by various researchers. With 
regards to susceptibility of various blood groups with obesity, in contrast our study 
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did not show any significant association between blood group antigens, BMI and 
blood pressure. 
Our study showed that the most common blood group in our study population was 
O, followed by A, B and AB. These results were disagree to those reported by 
studies conducted in Swat, District Nowshera, Lahore, Gujranwala, Multan, 
Faisalabad and many other cities of Punjab (103). Incompatible to our results, 
studies from northern area reported blood group A to be the commonest blood 
group (104). Considering the least common blood group, all aforementioned 
studies were inconsistent with our study demonstrated blood group AB to be the 
least commonest blood group (`105). It was also consistently shown that like in our 
results, all ethnicities demonstrated greater population of Rhesus Positive 
individuals as compared to Rhesus negative. Confirmatory studies are required to 
elucidate the relationship between obesity and blood groups and to delineate the 
mechanistic basis of this association. Blood type O was the prevalent ABO blood 
group in the present study. This trend of result is similar to the report from studies 
by Acquaye (106) in Ghana and Eruetal. (107) in Nigeria. Also, studies by Bhatti 
et al. (108) in India and   as well as Bhattacharyya et al. (109) in Pakistan have 
reported similar ABO blood group pattern. Worldwide distribution pattern has 
shown blood type O to be the most prevalent blood group followed by group B, 
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group A, and group AB (110), which is consistent with the findings in this present 
study.  
Blood group O is hypothesized to offer the maximum protection to people who live 
in areas endemic for infectious diseases. Hence, the incidence of this blood group 
is very high in tropical regions of the world where infectious diseases are common 
and the clinical importance of this distribution is illuminate by the low malaria 
parasitemia seen in individuals with the blood group O who live in West Africa 
(111). 
Reports in literature on the relationship between ABO blood group and BMI are 
inconsistent (112), with various authors associating increased BMI with the 
presence of particular ABO antigens, while others have shown no association 
between these two factors. Significant association was seen between ABO blood 
group and BMI among sampled populations from Pakistan (113), India (114), 








In the last we concluded that Blood group O+ was most prevalent followed by A+, 
B+, O-, AB+, A-, B- and AB-. Furthermore, prevalence of Rhesus positive factor 
was observed in this study. In addition, our study did not observe any significant 
difference regarding the association between blood group antigens (ABO and 














* Further studies need to be carried out to investigate relation between BMI and 
blood group O more thoroughly by investigating the mechanism behind it, to come 
up with more definitive conclusion. 
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